Immunotherapy Efficacy in SMARC-Altered Cancers: A pan-cancer analysis of clinical outcomes in response to immune checkpoint inhibition

Authors:
  • WEWesleigh Edwards
    Wesleigh Edwards
  • DNDaisuke Nishizaki
    Daisuke Nishizaki
  • DHDiana C. Hargreaves
    Diana C. Hargreaves
  • SKShumei Kato
    Shumei Kato
  • RKRazelle Kurzrock
    Razelle Kurzrock

Abstract
No abstract available
Funding Information
  • National Cancer Institute (P30CA023100)
  • National Institutes of Health (KL2TR002552)

This publication has 42 references indexed in Scilit: